China National Accord Medicines Corp Ltd (200028) - Total Liabilities

Latest as of September 2025: HK$29.01 Billion HKD

Based on the latest financial reports, China National Accord Medicines Corp Ltd (200028) has total liabilities worth HK$29.01 Billion HKD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

China National Accord Medicines Corp Ltd - Total Liabilities Trend (1992–2025)

This chart illustrates how China National Accord Medicines Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

China National Accord Medicines Corp Ltd Competitors by Total Liabilities

The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their total liabilities.

Liability Composition Analysis (1992–2025)

This chart breaks down China National Accord Medicines Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.50 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.57 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.57 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how China National Accord Medicines Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for China National Accord Medicines Corp Ltd (1992–2025)

The table below shows the annual total liabilities of China National Accord Medicines Corp Ltd from 1992 to 2025.

Year Total Liabilities Change
2025-12-31 HK$27.47 Billion +2.50%
2024-12-31 HK$26.80 Billion +0.78%
2023-12-31 HK$26.59 Billion +14.77%
2022-12-31 HK$23.17 Billion -6.42%
2021-12-31 HK$24.76 Billion +9.05%
2020-12-31 HK$22.71 Billion +25.03%
2019-12-31 HK$18.16 Billion +20.87%
2018-12-31 HK$15.02 Billion +21.01%
2017-12-31 HK$12.42 Billion +0.14%
2016-12-31 HK$12.40 Billion +62.04%
2015-12-31 HK$7.65 Billion -4.08%
2014-12-31 HK$7.98 Billion -8.73%
2013-12-31 HK$8.74 Billion +17.23%
2012-12-31 HK$7.46 Billion +19.52%
2011-12-31 HK$6.24 Billion +20.55%
2010-12-31 HK$5.18 Billion +18.83%
2009-12-31 HK$4.36 Billion +43.52%
2008-12-31 HK$3.03 Billion +27.05%
2007-12-31 HK$2.39 Billion +8.26%
2006-12-31 HK$2.21 Billion +225.07%
2005-12-31 HK$678.73 Million +39.09%
2004-12-31 HK$487.99 Million -26.67%
2003-12-31 HK$665.47 Million -7.30%
2002-12-31 HK$717.90 Million -4.75%
2001-12-31 HK$753.72 Million +778.18%
2000-12-31 HK$85.83 Million -1.03%
1999-12-31 HK$86.72 Million -24.01%
1998-12-31 HK$114.11 Million -31.94%
1997-12-31 HK$167.66 Million +87.37%
1996-12-31 HK$89.48 Million +77.00%
1995-12-31 HK$50.55 Million -11.09%
1994-12-31 HK$56.85 Million -41.32%
1993-12-31 HK$96.88 Million +4.01%
1992-12-31 HK$93.14 Million --

About China National Accord Medicines Corp Ltd

SHE:200028 China Medical Distribution
Market Cap
$126.42 Million
HK$990.36 Million HKD
Market Cap Rank
#19891 Global
#4685 in China
Share Price
HK$13.88
Change (1 day)
-0.86%
52-Week Range
HK$10.98 - HK$14.07
All Time High
HK$1125.97
About

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers new and special drugs and medications for chronic diseases. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources, as well as chemical drugs, OTC drugs, and healt… Read more